Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
21/05 | Manzo Pharmaceuticals, Inc. announced that it expects to receive $0.0005 million in funding | CI |
2015 | Manzo Pharmaceuticals Inc. Announces New Product Somnaid Release | CI |
Sales 2003 | 30.03L 25Cr | Sales 2004 | 30.7L 26Cr | Capitalization | 8.07T 7L |
---|---|---|---|---|---|
Net income 2003 | -30L -25Cr | Net income 2004 | -40L -33Cr | EV / Sales 2003 | - |
Net Debt 2003 | 7.3 609.14 | Net Debt 2004 | 6.51 543.25 | EV / Sales 2004 | - |
P/E ratio 2003 |
-0.73
x | P/E ratio 2004 |
-0.42
x | Employees | 12 |
Yield 2003 * |
-
| Yield 2004 |
-
| Free-Float | 0% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.1T | |
+15.54% | 7.85TCr | |
+12.05% | 900.15Cr | |
+58.17% | 496.1Cr | |
-14.94% | 483.61Cr | |
-.--% | 372.43Cr | |
+21.94% | 247.76Cr | |
-26.63% | 218.54Cr | |
+16.75% | 211.67Cr | |
-37.97% | 194.2Cr |
- Stock Market
- Equities
- MNZO Stock